XBIO Xenetic Biosciences Inc
Company Analysis
Latest News
🔴 Xenetic Biosciences is trading 6.3% down today in pre-market after wider second-quarter loss
Xenetic Biosciences is trading 6.3% down at $2.97 in pre-market after August 7 second-quarter report highlighted a wider $0.9 million net loss. - Royalty...
Xenetic Biosciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Analysts have provided limited formal coverage for Xenetic Biosciences heading into its Q2 2026 report, with no official consensus revenue or EPS estimates...
🟢 Xenetic Biosciences is trading 6.3% up today after reporting a $930,000 quarterly loss
Xenetic Biosciences is trading 6.3% up now at $3.02 after reporting a $930,000 quarterly loss. - Second-quarter 2026 results, released August 7, 2026,...
🟢 Xenetic Biosciences is trading 5% up today, extending a multi-day rebound amid sector strength
Xenetic Biosciences is trading 5% up today at $2.95, extending a multi-day rebound in its share price. • The move appears driven by broader risk-on sentiment...
🟢 Xenetic Biosciences is trading 12% up today amid a broader risk-on rally and rotation into high-beta biotech stocks
Xenetic Biosciences is trading 12% up at $2.98 amid a broader risk-on rally in U.S. equities and strength in the biotech sector. • Market commentators...
🟢 Xenetic Biosciences is trading 9.2% up today as traders rotate into high-beta biotech names
Xenetic Biosciences is trading 9.2% up today at $2.89 amid speculative momentum and a broader risk-on tone in U.S. equities. • The move appears driven by...
🟢 Xenetic Biosciences is trading 9.4% up today amid speculative momentum and broader risk-on sentiment
Xenetic Biosciences is trading at $2.75 (+9.40%) in pre-market sessions on speculative momentum and broader risk-on sentiment. - The stock closed at $2.66 on...
🟢 Xenetic Biosciences is trading 10.4% up today on speculative momentum despite no fresh news
Xenetic Biosciences is trading 10.4% up at $2.94 on speculative momentum despite a lack of company-specific news. • The stock's after-hours jump follows a...
🟢 Xenetic Biosciences is trading 6.38% up today, extending gains with no clear catalyst
Xenetic Biosciences is trading at $2.67 (+6.38%) today, extending gains from the previous session despite a lack of fresh company filings, press releases, or...
🟢 Xenetic Biosciences is trading 5.6% up today, extending gains without a clear catalyst
Xenetic Biosciences is trading 5.6% up at $2.62, extending yesterday’s gains despite a weak backdrop for the broader biotechnology sector. • There are no...
🟢 Xenetic Biosciences is trading 5.8% up today with no clear company-specific catalyst
Xenetic Biosciences is trading at $2.55 (+5.81%) with no direct catalyst found to explain the move. • The gain likely reflects normal small-cap volatility or...
🟢 Xenetic Biosciences is trading 5.6% up today, rebounding from a previous drop amid high volatility
Xenetic Biosciences is trading at $2.64 (5.6% up) in pre-market as the stock rebounds from a 5.3% drop at the July 27 close. • Recent price action appears to...
🟢 Xenetic Biosciences is trading 7.2% up today with no clear catalyst identified
Xenetic Biosciences is trading at $2.68 (7.2% up) following a volatile week that saw the stock close at $2.50 on July 27. - There are no fresh...
🔴 Xenetic Biosciences is trading 7% down today on no apparent news
Xenetic Biosciences is trading approximately 7% down today at $2.50 with no fresh, stock-specific news or filings explaining the move. • The decline appears...
🔴 Xenetic Biosciences is trading 5.6% down today, underperforming the broader biotech sector
Xenetic Biosciences is trading 5.6% down today at $2.70, underperforming a broadly positive biotech sector and stronger overall U.S. equity markets. • The...
🔴 Xenetic Biosciences is trading 5.6% down today amid a broader pullback in high-risk growth sectors
Xenetic Biosciences is trading 5.6% down today at $2.74 amid a broader pullback in higher-risk growth sectors. • The decline follows a general risk-off...
🔴 XBIO is trading 5.26% down today amid broader market risk-off sentiment
XBIO is trading at $2.74 (-5.26%) today as broader market weakness pressures small-cap biotech shares in the absence of company-specific news. - Major indices...